Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Fondazione Sisa (societa Italiana Per Lo Studio Della Arteriosclerosi)

Clinical trials sponsored by Fondazione Sisa (societa Italiana Per Lo Studio Della Arteriosclerosi), explained in plain language.

Not yet recruiting 1 Not yet finished but already full! 1

Can a new drug shrink dangerous plaque in the heart?

Disease control Not yet recruiting

This study aims to see if adding the drug Evinacumab to standard treatment can better control dangerous plaque buildup in the arteries of people with a rare, severe form of genetic high cholesterol (HoFH). Researchers will compare two groups of about 52 patients: one receiving Ev…

Sponsor: Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC